19.07.2017 • NewsElaine BurridgePPChemical

LyondellBasell Licenses PP Process to China

(c) Thomas Henderson/Getty Images
(c) Thomas Henderson/Getty Images

China’s Shaanxi Coal Yulin Energy and Chemical has chosen LyondellBasell’s Spherizone and Lupotech T process technologies for PP and LDPE plants being built in the Jingbian Chemical Industrial Park in Yulin City, Shaanxi province. Details on capacities and projected start-up dates were not disclosed.

Spherizone technology enables PP producers to expand their business and capture additional value through product differentiation, said Dan Coombs, executive vice president for global manufacturing, refining, projects and technology at the Houston-headquartered company.

Unlike other PP process technologies, LyondellBasell said Spherizone can produce entirely new families of propylene-based polymers using its unique multi-zone circulating reactor system.

In addition, the Netherlands-based, Texas-managed group noted that Lupotech T has high conversion rates and an effective heat recovery system, which offers fast grade changes and a high onstream factor. “Lupotech T is the clear market leader in high pressure tubular LDPE technology offering low operating and investment costs to our customers,” Coombs commented.

The Yulin plant will be the 14th worldwide to license Spherizone, which has been licensed for more than 4 million t of annual PP capacity since the technology was launched in 2016.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.